Annual Drug Patent Expirations for XYREM
Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for XYREM.
This drug has twenty-three patent family members in twenty-one countries.
The generic ingredient in XYREM is sodium oxybate. One supplier is listed for this compound. Additional details are available on the sodium oxybate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
